Ghazal Tansir | Oncology | Best Researcher Award

Dr. Ghazal Tansir | Oncology | Best Researcher Award

All India Institute Of Medical Sciences Delhi | India

Dr. Ghazal Tansir, is an accomplished medical oncologist and researcher with a distinguished academic and clinical trajectory, holding an MBBS from Vardhman Mahavir Medical College, an MD in Internal Medicine from PGIMER, and a DM in Medical Oncology from AIIMS, New Delhi. She has served as Senior Resident and Research Consultant at AIIMS and is currently Assistant Professor at CAPFIMS-AIIMS, New Delhi. Dr. Tansir is an active member of the American Society of Clinical Oncology, European Society of Medical Oncology, and Indian Society of Medical and Pediatric Oncology. She has received multiple honors, including gold medals in Community Medicine and Ophthalmology, the AK Gadpayle Gold Medal in MD, selection for the ACORD protocol development workshop, the ASCO Merit Award, the ESMO Travel Grant, and the IDEA Award by Conquer Cancer. Her research contributions encompass over fifteen publications, focusing on rare cancers, sarcomas, and translational oncology, with studies on synovial sarcoma, mesenchymal chondrosarcoma, desmoid tumors, Li Fraumeni syndrome, and young-onset lung cancer. Dr. Ghazal Tansir has presented her work extensively at international conferences, including ASCO, ESMO, and the Connective Tissue Oncology Society, earning recognition for clinical and translational research excellence, making her a highly impactful researcher in medical oncology.

Profile: Google Scholar

Featured Publications

Tansir, G., Gupta, C., Mehta, S., Kumar, P., Soneja, M., & Biswas, A. (2017). Expanded dengue syndrome in secondary dengue infection: A case of biopsy proven rhabdomyolysis induced acute kidney injury with intracranial and intraorbital bleeds. Intractable & Rare Diseases Research, 6(4), 314–318.

Kumar, P., Tansir, G., Sasmal, G., Dixit, J., & Sahoo, R. (2016). Left pulmonary agenesis with right lung bronchiectasis in an adult. Journal of Clinical and Diagnostic Research: JCDR, 10(9), OD15.

Tansir, G., Kumar, P., Pius, A., Sunny, S. K., & Soneja, M. (2019). Pseudo-pseudo Meigs’ syndrome: A rare presentation of systemic lupus erythematosus. Reumatismo, 71(2), 108–112.

Biswas, S., Kumar, P., Tansir, G., & Biswas, A. (2019). Case report: Cardiac tamponade in dengue hemorrhagic fever: An unusual manifestation of a common disease. The American Journal of Tropical Medicine and Hygiene, 101(2), 448.

Tansir, G., Rastogi, N., Ramteke, P., Kumar, P., Soneja, M., Biswas, A., Kumar, S., & Jorwal, P. (2017). Disseminated mucormycosis: A sinister cause of neutropenic fever syndrome. Intractable & Rare Diseases Research, 6(4), 310–313.

Cheng Yi | Oncology | Best Researcher Award

Mr. Cheng Yi | Oncology | Best Researcher Award

West China Hospital of Sichuan University | China

Mr. Cheng Yi, a distinguished Medical Doctor from Sichuan, currently serves as a professor and doctoral supervisor at the Cancer Center of West China Hospital, Sichuan University, and as an adjunct doctoral supervisor at Chengdu University of Traditional Chinese Medicine. He earned his Bachelor and Master of Medicine from Xi’an Jiaotong University, his Doctor of Medicine from Fudan University, and completed postdoctoral research at the University of Toronto. Since 1996, he has been deeply engaged in oncology clinical practice, scientific research, and teaching, advancing to professor and chief physician in 2006. His academic roles include standing committee and deputy director positions across multiple Chinese medical associations, reflecting his leadership in oncology and integrative medicine. With 138 publications, over 2,422 citations, and an h-index of 26, his research spans nanomedicine, cancer therapeutics, molecular oncology, immunotherapy, and systematic reviews, with impactful studies published in Journal of Materials Chemistry B, Nano Research, Frontiers in Oncology, PLoS One, and Journal of Cancer Research and Clinical Oncology. His international experience and consistent contributions to cancer treatment innovation highlight his strong candidacy for the Best Researcher Award, showcasing excellence in scientific impact, academic mentorship, and translational oncology research.

Profile: Scopus | Orcid

Featured Publications

Zhang, L.-N., Wei, Y.-F., Ran, X.-Y., Shi, L., Wang, Z.-Y., Chen, S.-Y., Yi, C., Yu, X.-Q., & Li, K. (2025). Liberating exciton transfer as a pioneering strategy to construct type I photosensitizers for hypoxia deep-seated metastases suppression. JACS Au. Advance online publication.

Tan, S., Feng, M., Zhou, N., Zhang, S., Yi, C., & Gou, H. (2025). DNA damage response and repair gene mutations predict clinical outcomes in biliary tract cancer. Cancer. Advance online publication.

Chen, P., Hou, W., Li, C., Liang, Q., Ma, L., Zhao, X., & Yi, C. (2025). Lived experiences of patients with advanced pancreatic cancer on patient-reported outcomes (PROs) management: A qualitative phenomenological study in Southwest China. BMJ Open, 15(1), e084259.

Ran, X.-Y., Xia, W.-L., Zhang, L.-N., Yu, X.-Q., Chen, P., Xie, K.-P., Zhao, Y., Yi, C., & Li, K. (2024). De novo design of type-I photosensitizer agents based on structure-inherent low triplet energy for hypoxia photodynamic therapy. Materials Horizons. Advance online publication.

Tan, S., Zhang, S., Zhou, N., Cai, X., Yi, C., & Gou, H. (2023). Efficacy and safety of fruquintinib dose-escalation strategy for elderly patients with refractory metastatic colorectal cancer: A single-arm, multicenter, phase II study. Cancer Medicine, 13(1), e6786.

Wei, Y., Zheng, L., Yang, X., Luo, Y., Yi, C., & Gou, H. (2023). Identification of immune subtypes and candidate mRNA vaccine antigens in small cell lung cancer. The Oncologist, 28(11), oyad193.